Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v2.4.0.6
Document and Entity Information
9 Months Ended
Sep. 30, 2012
Nov. 07, 2012
Document and Entity Information [Abstract]    
Entity Registrant Name ONCOGENEX PHARMACEUTICALS, INC.  
Entity Central Index Key 0000949858  
Document Type 10-Q  
Document Period End Date Sep. 30, 2012  
Amendment Flag false  
Document Fiscal Year Focus 2012  
Document Fiscal Period Focus Q3  
Current Fiscal Year End Date --12-31  
Entity Filer Category Accelerated Filer  
Entity Common Stock, Shares Outstanding   14,656,916